Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Physical limitations take a significant toll in breast cancer survivors

27.09.2010
Basic physical limitations following breast cancer treatment can have far-reaching consequences that substantially affect how long a patient lives.

According to a new study published online in “The Journal of the National Cancer Institute,” breast cancer survivors with functional limitations – an inability to perform normal daily activities – caused by the disease or its treatment are more likely to die because of overall poorer health.

The scientists found that survivors who reported physical limitations after breast cancer treatment have the same risk of dying from breast cancer as those without limitations but are more likely to die from other diseases. In particular, investigators found that older women, as well as overweight breast cancer patients, were more likely to experience functional impairments for at least 18 months after treatment.

The research, the first of its kind, points to risk factors where, with simple modifications in habits that allow more physical activity, health might be greatly improved.

The impairments, affecting motion, strength and dexterity, include an inability to kneel, to lift items heavier than 10 pounds or to handle small objects, to stand in place, to sit for long periods, to walk up and down a flight a stairs, to walk two or three city blocks.

“Our study provides evidence of why it is important to develop interventions that improve physical function, to mitigate the adverse effects of physical limitations,’’ said Dejana Braithwaite, PhD, first author of the study and assistant professor of Cancer Epidemiology at UCSF’s Helen Diller Family Comprehensive Cancer Center. “Intervention strategies – on the part of the individual, the community and the health provider – should emphasize physically active lifestyles.’’

Braithwaite collaborated with researchers at the Kaiser Permanente Northern California, the University of Utah, the University of California and Brock University in Canada.

“When we talk about improving physical function, we are talking about improving a woman’s ability to perform normal functions of everyday life, like walking around the block, getting up easily from a chair or carrying a heavy bag of groceries,’’ said Bette Caan, DRPH, senior author and principal investigator of the Life After Cancer Epidemiology Study and Senior Research Scientist at Kaiser Permanente Division of Research. “These activities appear to make a difference in a woman’s chance of survival after a breast cancer diagnosis.’’

With better detection and treatment, more breast cancer patients are surviving longer.

According to the National Cancer Institute, an estimated 2.5 million women with a history of breast cancer were alive in 2006 – most of them cancer-free. The overall five-year survival rate for localized breast cancer is 98 percent, reports the American Cancer Society, while the survival rate for breast cancer that has spread to the chest wall or lymph nodes is in the 80 percent range; at least 25 percent of breast cancer patients whose disease has metastasized survive five or more years.

Despite improved survival rates, many patients struggle with physical limitations after treatment – as many as 39 percent, according to the new findings – yet little attention has been paid to those limitations and related problems, particularly among older women.

To determine how physical limitations following initial breast cancer treatment affect mortality, the scientists studied 2,202 women in California and Utah with breast cancer, questioning them about endurance, strength, muscular range of motion, and small muscle dexterity following initial treatment such as chemotherapy, radiation therapy or hormone therapy. The women were part of the Life After Cancer Epidemiology cohort, and were followed for up to 11 years after diagnosis.

Outcomes differed according to disease stage. Women with localized cancer had higher rates of non-breast cancer death due to functional limitations than those with more advanced disease. In addition, women with functional limitations may have poorer treatment tolerance because they are more likely to be older, less physically active, and overweight or obese. As a result, the authors speculate that women with good physical function who tolerated therapy well might be over-represented in the group with more advanced disease.

“There is increasing evidence that regular physical activity, as little as 30 minutes of moderate intensity walking each day, can reduce the risk of breast cancer recurrence,’’ said study co-author Patricia Ganz, MD, a medical oncologist and director of cancer prevention and control at UCLA’s Jonsson Comprehensive Cancer Center. “Women with functional limitations are less likely to be able to maintain regular physical activity and would likely benefit from intervention to reduce their limitations and increase physical activity.’’

Though the researchers did not specifically study the mechanism, they suggest that functional limitations may be associated with chronic inflammation, a key aspect of the immune system’s defenses, which can lead to diminished function of organs or systems.

In an accompanying editorial, Harvey Jay Cohen, MD, director of the Center for the Study of Aging and Human Development at Duke University Medical Center said the research “enhances our broader understanding of the issues surrounding functional status assessment and cancer outcomes.’’ http://jnci.oxfordjournals.org/content/early/2010/09/22/jnci.djq365.full.pdf+html.

The research was supported by grants from the National Institutes of Health, National Cancer Institute, Bay Area Breast Cancer SPORE (Specialized Program of Research Excellence), the Hellman Family Foundation, and the Robert Wood Johnson Foundation Health & Society Scholars Program at the University of California, San Francisco and Berkeley. Data were derived from the LACE study, which was supported by funds from the National Cancer Institute and by the Utah Cancer Registry with additional support from the Utah Department of Health.

UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care.

The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and the society at large. It seeks to understand the determinants of illness and well-being and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 500-plus staff is working on more than 250 epidemiological and health services research projects. For more information, visit http://www.dor.kaiser.org.

Additional contact: Maureen McInaney-Jones, Communications Manager, Kaiser Permanente Division of Research, Northern California, 510-891-3173; Maureen.McInaney@kp.org

Elizabeth Fernandez | EurekAlert!
Further information:
http://www.ucsf.edu

More articles from Health and Medicine:

nachricht How cancer metastasis happens: Researchers reveal a key mechanism
19.01.2018 | Weill Cornell Medicine

nachricht Researchers identify new way to unmask melanoma cells to the immune system
17.01.2018 | Duke University Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Artificial agent designs quantum experiments

On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.

We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Let the good tubes roll

19.01.2018 | Materials Sciences

How cancer metastasis happens: Researchers reveal a key mechanism

19.01.2018 | Health and Medicine

Meteoritic stardust unlocks timing of supernova dust formation

19.01.2018 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>